Three things to know:
1. In March, the assets will be transferred into a new company wholly-owned by Kyocera International called Kyocera Medical Technologies.
2. Kyocera manufactures artificial joints and dental implants, among other products. The company received FDA 510(k) clearance for its artificial hip joints and began selling them in the U.S. in 2017.
3. Kyocera plans to expand its U.S. medical equipment business through this purchase.
More articles on devices:
Spinal Elements introduces industry veteran as chairman: 4 takeaways
3 things to know about SpineSource
Orthopedic diagnostics company closes $18.3M funding round: 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
